These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
137 related articles for article (PubMed ID: 33591038)
1. Rituximab as an Adjuvant Rescue Treatment for Ocular Cicatricial Pemphigoid. Bevans SL; Parker J; Ivey JM; Pavlidakey P; Sami N Cornea; 2021 Nov; 40(11):1440-1444. PubMed ID: 33591038 [TBL] [Abstract][Full Text] [Related]
2. Rituximab in the treatment of ocular cicatricial pemphigoid: a retrospective cohort study. You C; Lamba N; Lasave AF; Ma L; Diaz MH; Foster CS Graefes Arch Clin Exp Ophthalmol; 2017 Jun; 255(6):1221-1228. PubMed ID: 28154932 [TBL] [Abstract][Full Text] [Related]
3. Management of Ocular Cicatricial Pemphigoid with Intravenous Immunoglobulin Monotherapy. Ma L; You C; Hernandez M; Maleki A; Lasave A; Schmidt A; Stephenson A; Zhao T; Anesi S; Foster CS Ocul Immunol Inflamm; 2019; 27(4):636-642. PubMed ID: 29517945 [No Abstract] [Full Text] [Related]
4. Combination of rituximab and intravenous immunoglobulin for recalcitrant ocular cicatricial pemphigoid: a preliminary report. Foster CS; Chang PY; Ahmed AR Ophthalmology; 2010 May; 117(5):861-9. PubMed ID: 20045562 [TBL] [Abstract][Full Text] [Related]
5. [Ocular Cicatricial Pemphigoid - a Retrospective Study]. Szabó E; Palos M; Skalická P Cesk Slov Oftalmol; 2016 Feb; 72(1):283-92. PubMed ID: 27041284 [TBL] [Abstract][Full Text] [Related]
6. Combined Use of Rituximab and Intravenous Immunoglobulin for Severe Autoimmune Cicatricial Conjunctivitis-An Interventional Case Series. Steger B; Madhusudan S; Kaye SB; Stylianides A; Romano V; Maqsood SE; Harper J; Ahmad S Cornea; 2016 Dec; 35(12):1611-1614. PubMed ID: 27661067 [TBL] [Abstract][Full Text] [Related]
7. Long-term remission of ocular cicatricial pemphigoid off immunomodulatory therapy. You C; Ma L; Anesi SD; Stephen Foster C Eur J Ophthalmol; 2018 Mar; 28(2):157-162. PubMed ID: 29077176 [TBL] [Abstract][Full Text] [Related]
8. Atopy in Patients With Ocular Cicatricial Pemphigoid. Ebrahimiadib N; Hernandez M; Modjtahedi BS; Roohipoor CR; Foster CS Cornea; 2018 Apr; 37(4):436-441. PubMed ID: 29341971 [TBL] [Abstract][Full Text] [Related]
11. Perioperative Management and Long-Term Outcomes in Ocular Cicatricial Pemphigoid Patients Undergoing Cataract Surgery. He Y; Quan Z; Zhang R; Ji Z; Jia J; Liu H; Zhang C; He B; Ren Y; Feng Y Oxid Med Cell Longev; 2022; 2022():2496649. PubMed ID: 35535356 [TBL] [Abstract][Full Text] [Related]
12. Pentoxifylline (anti-tumor necrosis factor drug): effective adjuvant therapy in the control of ocular cicatricial pemphigoid. El Darouti MA; Fakhry Khattab MA; Hegazy RA; Hafez DA; Gawdat HI Eur J Ophthalmol; 2011; 21(5):529-37. PubMed ID: 21279976 [TBL] [Abstract][Full Text] [Related]
13. A conjunctival-sparing surgical technique for lower eyelid cicatricial entropion repair in ocular cicatricial pemphigoid. Choung H; Reshef ER; Tanking T; Freitag SK Orbit; 2020 Feb; 39(1):23-30. PubMed ID: 30732510 [No Abstract] [Full Text] [Related]
14. A nonrandomized comparison of the clinical outcome of ocular involvement in patients with mucous membrane (cicatricial) pemphigoid between conventional immunosuppressive and intravenous immunoglobulin therapies. Letko E; Miserocchi E; Daoud YJ; Christen W; Foster CS; Ahmed AR Clin Immunol; 2004 Jun; 111(3):303-10. PubMed ID: 15183151 [TBL] [Abstract][Full Text] [Related]
15. Clinical Characteristics and Outcomes of Ocular Cicatricial Pemphigoid: A Cohort Study and Literature Review. Fremont F; Pelissier-Suarez C; Fournié P; Porterie M; Thevenin A; Astudillo L; Paricaud K; Gualino V; Soler V; Pugnet G Cornea; 2019 Nov; 38(11):1406-1411. PubMed ID: 31356420 [TBL] [Abstract][Full Text] [Related]
16. Characteristics of patients with ocular cicatricial pemphigoid referred to major tertiary hospital. Goldich Y; Ziai S; Artornsombudh P; Avni-Zauberman N; Elbaz U; Rootman DS; Chan CC Can J Ophthalmol; 2015 Apr; 50(2):137-42. PubMed ID: 25863854 [TBL] [Abstract][Full Text] [Related]